A Randomized, Open-Label Study of HLX10 Plus Chemotherapy (Carboplatin-Etoposide) in Comparison with Atezolizumab Plus Chemotherapy in Previously Untreated US Patients with Extensive Stage Small Cell Lung Cancer (ES-SCLC)

Protocol No
SHB-HLX10-005-SCLC301-E
Staff Member
Hui-Zi Chen
Phase
III
Summary

This project is being done to compare the effects of Serplulimab (HLX10) plus chemotherapy with Atezolizumab plus chemotherapy on you and your disease.
Objective
A randomized study to compare Atezolizumab plus Chemotherapy vs HLX10 plus Chemo in ES-SCLC
Study Sites
Froedtert Hospital
Status
OPEN TO ACCRUAL
Categories
Cancer, Lung, Thoracic Cancers
ClinicalTrials.gov
https://www.clinicaltrials.gov/study/NCT05468489